We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+4.24%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$4.31B
AUM Growth
+$60.9M
Cap. Flow
-$73.3M
Cap. Flow %
-1.7%
Top 10 Hldgs %
16.36%
Holding
590
New
34
Increased
175
Reduced
265
Closed
22

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$26.3M
2
OKE icon
Oneok
OKE
+$18.5M
3
BAX icon
Baxter International
BAX
+$17.2M
4
AVY icon
Avery Dennison
AVY
+$12.8M
5
ICUI icon
ICU Medical
ICUI
+$11.8M

Top Sells

Rank Stock Value
1
AYI icon
Acuity Brands
AYI
+$23.3M
2
PPG icon
PPG Industries
PPG
+$22.4M
3
EFX icon
Equifax
EFX
+$19M
4
OKS
Oneok Partners LP
OKS
+$17.7M
5
MDT icon
Medtronic
MDT
+$17.5M

Sector Composition

Rank Sector Weight
1 Healthcare 17.99%
2 Industrials 16.07%
3 Financials 14.59%
4 Technology 13.97%
5 Consumer Discretionary 9.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WAB icon
351
Wabtec
WAB
$50.1B
$1.09M 0.03%
14,372
-829
-5% -$63.8K
BAC icon
352
Bank of America
BAC
$439B
$1.04M 0.02%
41,057
+1,106
+3% +$26.8K
BDX icon
353
Becton Dickinson
BDX
$44B
$1.04M 0.02%
5,424
+374
+7% +$72.5K
XEL icon
354
Xcel Energy
XEL
$50.8B
$1.03M 0.02%
21,835
+2,200
+11% +$106K
ACHC icon
355
Acadia Healthcare
ACHC
$3.08B
$1.02M 0.02%
21,352
+65
+0.3% +$3.17K
FTV icon
356
Fortive
FTV
$19.1B
$1.01M 0.02%
22,648
-2,529
-10% -$105K
IVV icon
357
iShares Core S&P 500 ETF
IVV
$870B
$1M 0.02%
3,961
-325
-8% -$80.7K
INGR icon
358
Ingredion
INGR
$6.41B
$991K 0.02%
8,213
-2,489
-23% -$303K
CVS icon
359
CVS Health
CVS
$136B
$975K 0.02%
11,986
-285
-2% -$22.5K
BP icon
360
BP
BP
$110B
$952K 0.02%
27,472
-1,815
-6% -$57.7K
GD icon
361
General Dynamics
GD
$105B
$936K 0.02%
4,553
+588
+15% +$118K
RDS.A
362
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$934K 0.02%
15,425
+315
+2% +$17.6K
AZPN
363
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$930K 0.02%
14,802
CTSH icon
364
Cognizant
CTSH
$22.4B
$928K 0.02%
12,797
-375
-3% -$26.3K
AZO icon
365
AutoZone
AZO
$50B
$916K 0.02%
1,540
-1,026
-40% -$546K
MA icon
366
Mastercard
MA
$488B
$909K 0.02%
6,437
-880
-12% -$116K
AAP icon
367
Advance Auto Parts
AAP
$3.46B
$908K 0.02%
9,152
-3,498
-28% -$353K
BX icon
368
Blackstone
BX
$106B
$888K 0.02%
26,625
ETN icon
369
Eaton
ETN
$152B
$884K 0.02%
11,508
-27
-0.2% -$2.04K
BOH icon
370
Bank of Hawaii
BOH
$3.22B
$883K 0.02%
10,598
SXT icon
371
Sensient Technologies
SXT
$5.42B
$882K 0.02%
11,461
-69
-0.6% -$5.23K
MD icon
372
Pediatrix Medical
MD
$2.17B
$878K 0.02%
20,371
-240
-1% -$11.4K
ZBH icon
373
Zimmer Biomet
ZBH
$18B
$875K 0.02%
7,694
-1,964
-20% -$227K
VTR icon
374
Ventas
VTR
$48.9B
$863K 0.02%
13,252
-924
-7% -$62.3K
DUK icon
375
Duke Energy
DUK
$101B
$849K 0.02%
10,115
+1,000
+11% +$85.6K

Similar funds

Segall Bryant & Hamill's Q3 2017 Portfolio in Review

As of Q3 2017, Segall Bryant & Hamill held 590 positions worth $4.31B, up 1.4% from $4.24B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Segall Bryant & Hamill's Q3 2017 filing shows 34 new, 175 increased, 265 reduced and 22 closed positions. Its largest new stake was ICU Medical: 67,735 shares worth $12.6M. The largest sale was Acuity Brands, an estimated $23.3M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.

  • Segall Bryant & Hamill's largest Q3 2017 buy was ICU Medical: 67,735 shares worth $12.6M.
  • Segall Bryant & Hamill added most to Thermo Fisher Scientific in Q3 2017, an estimated $26.3M increase.
  • Segall Bryant & Hamill's biggest Q3 2017 reduction was Acuity Brands, cutting an estimated $23.3M.
  • Segall Bryant & Hamill fully exited Oneok Partners LP in Q3 2017, selling an estimated $17.7M.
  • Segall Bryant & Hamill's ten largest holdings make up 16% of its $4.31B portfolio in Q3 2017.
  • Segall Bryant & Hamill opened 34 new positions and closed 22 in Q3 2017.
  • Segall Bryant & Hamill's portfolio value rose 1.4% quarter-over-quarter to $4.31B.

Based on Segall Bryant & Hamill's 13F filing for Q3 2017, filed 14 Nov 2017.